CGM
The company says the new facility will create hundreds of jobs and expand production capabilities for continuous glucose monitoring systems.
The announcement comes less than a year after Dexcom announced a strategic partnership and $75 million investment in the health-tracking ring maker.
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.
The CGM biosensor offers high antinoise ability and tunable sensitivity and resolution.
The hydrogel-based sensor can continuously monitor cholesterol and lactate on the skin.
Also, new AI-powered mobile apps in Hong Kong support at-home stroke rehabilitation and the mental health of parents of children with special education needs.
i-SENS is also seeking CE certification for its CGM product in Europe.
The CGM-based service will begin in Q4.
Also, medical device unicorn Molbio has taken a 70% stake in digital x-ray manufacturer Prognosys.
The partnership allows DarioHealth to integrate data from Dexcom's continuous glucose monitors in its chronic-condition management platform.